Eating walnuts, soybean can ward off diabetes risk

Image
ANI Washington D.C. [U.S.A.]
Last Updated : Oct 12 2017 | 10:22 AM IST

Eating a diet rich in omega-6 polyunsaturated fats, particularly found in walnuts, fish, soybean and sunflower oils, can significantly reduce a person's risk of developing Type-2 diabetes, suggests a recent study.

These findings shed a new light on the potential health benefits of omega-6, which is found in bean and seed oils such as soybean and sunflower oils and in nuts, and support clinical recommendations to increase dietary intake of omega-6 rich foods.

The results indicate that the individuals, who had the highest blood level of linoleic acid, the major omega-6 fat, were 35 per cent less likely to develop Type-2 diabetes in the future than those who had the least amount.

Lead author Dr. Jason Wu from The George Institute for Global Health in Sydney said that a simple change in diet might protect people from developing Type-2 diabetes, which has reached alarming levels around the world.

Senior study author Dariush Mozaffarian from the Tufts University in Massachusetts stated that the people involved in the study were generally healthy and were not given specific guidance on what to eat. Yet those who had the highest levels of blood omega-6 markers had a much lower chance of developing Type-2 diabetes.

The team analysed data from 20 studies involving 39,740 adults from 10 countries, in whom 4,347 new cases of diabetes occurred over time.

They tested the participants for two key omega-6 markers - linoleic acid and arachidonic acid.

Linoleic acid was associated with lower risk, while levels of arachidonic acid were not significantly associated with either higher or lower risk of diabetes.

Dr. Wu noted that they the major omega-6 fat is linked to lower risk of Type-2 diabetes.

Linoleic acid is not formed in the body and can only be obtained from the diet.

The results suggest that eating foods rich in linoleic acid may lower risk of Type-2 diabetes.

The research appeared in the Lancet Diabetes and Endocrinology journal.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 12 2017 | 10:22 AM IST

Next Story